XML 73 R57.htm IDEA: XBRL DOCUMENT v3.20.4
Share-based Compensation (Tables)
 12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Restricted Stock Award and Stock Option Transactions
The Corporation's restricted stock award transactions were as follows:
 Number of AwardsWeighted-Average Grant Date Fair Value Per Award
Outstanding at December 31, 20172,639,663 $13.65 
Outstanding at December 31, 2017 as adjusted for conversion1,341,136 26.86 
Granted387,909 42.61 
Forfeited/canceled(119,366)29.77 
Vested(446,447)24.09 
Outstanding at December 31, 20182,289,446 $16.70 
Outstanding at December 31, 2018 as adjusted for conversion1,163,232 32.87 
Granted269,915 40.82 
Forfeited/canceled(136,489)34.18 
Vested(408,353)34.37 
Outstanding at December 31, 2019888,305 40.67 
Granted54,040 25.91 
Forfeited/canceled(12,927)39.96 
Vested(424,256)41.08 
Outstanding at December 31, 2020505,162 $38.57 
Schedule of Total Expense for Restricted Stock Awards
The following table provides information regarding total expense for restricted stock awards:
 Year Ended December 31,
(In thousands)202020192018
Restricted stock expense related to employees(1)
$26,906 $15,218 $16,549 
Restricted stock expense related to directors(2)
918 950 — 
Total restricted stock expense$27,824 $16,168 $16,549 
(1)Included in "Compensation and employee benefits" in the Consolidated Statements of Income.
(2)Included in "Other noninterest expense" in the Consolidated Statements of Income.
Share-based Compensation
A summary of activity for the Corporation's stock options is presented below:
Non-Vested Stock Options OutstandingStock Options Outstanding
 Number of OptionsWeighted-average Exercise PriceNumber of OptionsWeighted-average Exercise Price
Outstanding at December 31, 2017— $— 366,000 $15.75 
Outstanding at December 31, 2017 as adjusted for conversion— — 185,964 31.00 
Exercised— — (185,964)31.00 
Outstanding at December 31, 2018— — — — 
Acquired in the TCF/Chemical Merger(1)
127,906 39.38 520,379 29.48 
Exercised— — (25,602)30.10 
Forfeited/canceled(5,953)32.81 — — 
Expired— — (756)32.81 
Vested(1,144)46.95 1,144 46.95 
Outstanding at December 31, 2019120,809 39.63 495,165 29.48 
Exercised— — (101,913)21.07 
Forfeited/canceled(3,659)38.18 — — 
Expired— — (53,044)39.08 
Vested(61,428)38.26 61,428 38.26 
Outstanding at December 31, 202055,722 $41.23 401,636 $31.69 
Exercisable/vested at December 31, 2020401,636 $31.69 
(1)Options acquired in the TCF/Chemical Merger expire ten years from the date of grant and vest ratably over a five-year period.
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
A summary of the activity for RSUs for the years ended December 31, 2020, 2019 and 2018 is presented below:
 Number of UnitsWeighted-average Grant Date Fair Value Per Unit
Outstanding at December 31, 2017360,988 $15.17 
Outstanding at December 31, 2017 as adjusted for conversion183,419 29.86 
Granted60,181 43.78 
Forfeited/canceled(10,411)28.59 
Vested(26,609)28.81 
Outstanding at December 31, 2018406,575 17.33 
Outstanding at December 31, 2018 as adjusted for conversion206,580 34.11 
Granted638,138 41.99 
Acquired in the TCF/Chemical Merger(1)
879,779 47.36 
Forfeited/canceled(26,347)43.43 
Vested(186,330)38.11 
Outstanding at December 31, 20191,511,820 44.49 
Granted1,542,671 24.67 
Forfeited/canceled(83,818)32.06 
Vested(955,159)41.51 
Outstanding at December 31, 20202,015,514 31.25 
(1)Inclusive of certain Legacy TCF PRSUs which were converted at their maximum payout into 55,022 TRSUs with a weighted-average grant date fair value per unit of $42.06.